Investors / United States / Taiho Ventures
Taiho Ventures
Corporate VC · Menlo Park, CA, United States · North America
Taiho Ventures is the corporate venture arm of Taiho Pharmaceutical Co., Ltd., a Japanese specialty pharmaceutical company. It invests in early stage private companies strategically relevant to Taiho Pharmaceutical, and also considers company creation, spinouts and option-type investments as well as pure equity investments.
Invests inHealthcare & Biotech
In its own wordsoncologydrug discoverybiotechplatform technologydiagnosticsdigital health
Your fit with Taiho Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsTaiho Ventures lists 23 checked portfolio companies on its own site and is named in 5 funding rounds, 2 of them as lead. Its most frequent entry is Series B, 50% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 78% of its companies are based in United States. It invests most often alongside UTokyo Innovation Platform, Aisling Capital and Canaan.
Counts come from funding rounds that name Taiho Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Taiho Ventures' whole history. Rounds on record name 5 companies; its own site lists 23. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 25% |
| Series A | 0% |
| Series B | 50% |
| Growth | 25% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 1 |
| '26 | 4 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 57th | 23 companies |
| Recent activity | 82th | 4 rounds in 12 months |
| Early stage | 60th | 25% of entries at pre-seed or seed |
| Evidence | 83th | 13% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 78th | 5 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| UTokyo Innovation Platform | 3 |
| Aisling Capital | 2 |
| Canaan | 2 |
| K2 HealthVentures | 2 |
| Lilly Asia Ventures | 2 |
| MPM BioImpact | 2 |
| Mission BioCapital | 2 |
| Nextech Invest | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2087%
- No longer answers00%
- Points to another company313%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with UTokyo Innovation Platform
Compare Taiho Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Taiho Ventures| Date | Company | Stage |
|---|---|---|
| 29 Oct 2026 | Series C+ | |
| 6 May 2026 | Seed | |
| 18 Mar 2026 | Series B Led | |
| 8 Jan 2026 | Series B | |
| 9 Sept 2025 | Round Led |
Round details for Taiho Ventures
Amounts, full round histories and every co-investor in Taiho Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
23 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Anavo Therapeutics develops therapeutic programs using its IGNITE platform to target phosphatases for drug discovery | Healthcare & Biotech | Portfolio page | ||
| Arcus Biosciences creates medicines by advancing validated biology with exceptional chemistry. | Healthcare & Biotech | Portfolio page | ||
| Breakpoint Therapeutics modulates DNA damage responses to cure cancer | Healthcare & Biotech | Portfolio page | ||
| cellvie develops medicines from cells, specifically using mitochondria for therapeutic purposes, including treating genetic diseases and ischemia-reperfusion injury | Healthcare & Biotech | Sept 2025Round | Page + round | |
| Crossbow Therapeutics develops antibody therapeutics to treat cancer. | Healthcare & Biotech | Mar 2026Series B | Funding round | |
| Portfolio page | ||||
| Delphia Therapeutics is developing new cancer medicines using a precision medicine approach called activation lethality. | Healthcare & Biotech | Portfolio page | ||
| Dren Bio is a clinical-stage biopharmaceutical company that discovers and develops novel antibody therapeutics for cancer and other serious diseases. | Healthcare & Biotech | Oct 2026Series C+ | Page + round | |
| EpiBiologics develops medicines that use bispecific antibodies to selectively degrade disease-causing extracellular proteins | Healthcare & Biotech | Jan 2026Series B | Page + round | |
Healthcare & Biotech | Portfolio page | |||
Healthcare & Biotech | Portfolio page | |||
| LiberoThera develops innovative drugs using cell membrane protein preparation technology and non-natural amino acid introduction technology. | Healthcare & Biotech | Portfolio page | ||
| Light Horse Therapeutics is a small molecule drug discovery company that applies precision gene editing to discover novel targets for diseases. | Healthcare & Biotech | Portfolio page | ||
| Magnet Biomedicine develops therapeutics using induced proximity medicines for the treatment of human disease. | Healthcare & Biotech | Portfolio page | ||
| NextCure, Inc. develops pipeline products and technologies | Healthcare & Biotech | Portfolio page | ||
| Normunity is developing novel anti-cancer therapies that target the interface of the immune system and the tumor. | Healthcare & Biotech | Portfolio page | ||
| Oric Pharmaceuticals develops and commercializes innovative therapies to address cancer resistance | Healthcare & Biotech | Portfolio page | ||
| Signadori Bio develops next-generation in vivo monocyte immunotherapy to treat solid tumors. | Healthcare & Biotech | May 2026Seed | Funding round | |
| STORM Therapeutics develops and evaluates RNA modifying enzyme inhibitors for use in human clinical trials. | Healthcare & Biotech | Portfolio page | ||
| Theolytics is developing systemically deliverable immunotherapies based on oncolytic adenoviruses to target solid tumours. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- taihoventures.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 9 Sept 2025
- Companies checked
- 23
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Taiho Ventures' profile as data
Pull Taiho Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/taihoventures.com
# also
GET /v1/firms/taihoventures.com/portfolio
GET /v1/firms/taihoventures.com/coinvestors
GET /v1/firms/taihoventures.com/news